Get started
Author

Maria Almena-Carrasco

Observed name: María Almena Carrasco
Institution: Servier (France)
ORCID: 0000-0002-3513-0919
Observed ORCID: 0000-0002-3513-0919
OpenAlex ID: A5011935547
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
2020 · Reuben Benjamin, Charlotte Graham, et al. · The Lancet · 391
UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial
2022 · Reuben Benjamin, Nitin Jain, et al. · The Lancet Haematology · 159
Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma
2021 · Charlotte Elizabeth Graham, Agnieszka Jozwik, et al. · Leukemia · 28
PDF
Clinical Pharmacology and Determinants of Response to UCART19, an Allogeneic Anti-CD19 CAR-T Cell Product, in Adult B-cell Acute Lymphoblastic Leukemia
2022 · Sandra Dupouy, Ibtissam Marchiq, et al. · Cancer Research Communications · 23
PDF
Mechanistic Modeling of the Interplay Between Host Immune System, IL-7 and UCART19 Allogeneic CAR-T Cells in Adult B-cell Acute Lymphoblastic Leukemia
2022 · Thibaud Derippe, Sylvain Fouliard, et al. · Cancer Research Communications · 19
Abstract 3737: Molecular and early clinical characterization of the anti-CD73 antibody S095024 (Sym024)
2024 · Anna Spreafico, Jordi R. Ahnert, et al. · Cancer Research · 8
Allogeneic Anti-CD19 CAR T Cells Manufactured from Healthy Donors Provide a Unique Cellular Product with Distinct Phenotypic Characteristics Compared to CAR T Cells Generated from Patients with Mature B Cell Malignancies
2019 · Charlotte Graham, Agnieszka Jozwik, et al. · Blood · 6
Data from Clinical Pharmacology and Determinants of Response to UCART19, an Allogeneic Anti-CD19 CAR-T Cell Product, in Adult B-cell Acute Lymphoblastic Leukemia
2023 · Sandra Dupouy, Ibtissam Marchiq, et al.
Data from Mechanistic Modeling of the Interplay Between Host Immune System, IL-7 and UCART19 Allogeneic CAR-T Cells in Adult B-cell Acute Lymphoblastic Leukemia
2023 · Thibaud Derippe, Sylvain Fouliard, et al.
Supplementary Tables S1-S4 from Clinical Pharmacology and Determinants of Response to UCART19, an Allogeneic Anti-CD19 CAR-T Cell Product, in Adult B-cell Acute Lymphoblastic Leukemia
2023 · Sandra Dupouy, Ibtissam Marchiq, et al.
Supplementary Data S1 from Mechanistic Modeling of the Interplay Between Host Immune System, IL-7 and UCART19 Allogeneic CAR-T Cells in Adult B-cell Acute Lymphoblastic Leukemia
2023 · Thibaud Derippe, Sylvain Fouliard, et al.
Supplementary Materials & Methods SM1 from Clinical Pharmacology and Determinants of Response to UCART19, an Allogeneic Anti-CD19 CAR-T Cell Product, in Adult B-cell Acute Lymphoblastic Leukemia
2023 · Sandra Dupouy, Ibtissam Marchiq, et al.
PDF
Supplementary Figures S1-S9 from Clinical Pharmacology and Determinants of Response to UCART19, an Allogeneic Anti-CD19 CAR-T Cell Product, in Adult B-cell Acute Lymphoblastic Leukemia
2023 · Sandra Dupouy, Ibtissam Marchiq, et al.
Data from Mechanistic Modeling of the Interplay Between Host Immune System, IL-7 and UCART19 Allogeneic CAR-T Cells in Adult B-cell Acute Lymphoblastic Leukemia
2023 · Thibaud Derippe, Sylvain Fouliard, et al.
Función del diacilglicerol en el desarrollo, activación y homeostasis de las células T
2010 · María Almena Carrasco · Biblos-e Archivo (Universidad Autónoma de Madrid)
PDF
Works count: 15
Citation count: 634
H-index: 6
I10-index: 5
Year
Topic
Type